Healthcare and life sciences are some of the largest and fastest-growing industries in the world, in addition to being the most regulated, with rapidly changing rules and regulations that often conflict from one country to another. Healthcare and life sciences companies face a number of challenges, including trying to understand how these laws impact their market and M&A strategies while contending with rising R&D costs, loss of patent protection of blockbuster drugs, pricing pressures, and competition from generics. Rapid convergence of the healthcare, life sciences and technology sectors requires even more legal expertise given the additional data privacy and intellectual property concerns.
As one of the first law firms to advise pharmaceutical companies on their global expansion 50 years ago, our healthcare and life sciences lawyers understand the challenges industry players face and what it takes to overcome them. As trusted advisors to the world’s largest pharmaceutical, biotech, medical device and healthcare services companies, our team of more than 500 lawyers includes molecular biology, biotechnology, pharmacology, nursing and bioethics experts as well as former life sciences professionals who apply their expertise to help clients overcome legal and business challenges.
For the past five years, we have ranked number one for healthcare M&A by deal volume, completing more cross-border transactions than any other law firm. Our global healthcare and life sciences team not only works across borders, but across practice areas to coordinate the worldwide protection of healthcare patents and brands, develop global transfer pricing and tax planning strategies, and represent clients in product liability cases and complex disputes. We also advise on the legal and regulatory aspects of healthcare and life sciences advertising and marketing, clinical trials, competition and trade, commercial agreements, data privacy, employment issues, and market entry.
